UP STUDY - Decipher Persistent Critical Illness Through in Deep Clinical Phenotyping.
Recruiting now
Conditions studied: Critical Illness, Recovery Outcomes, Critical Care, Intensive Care, Critical Care, Critical Care Medicine
In brief
Persistent Critical Illness (PCI) is a condition that affects some patients who remain in the Intensive Care Unit (ICU) for a long time, usually more than 10-14 days. It is estimated to occur in 5-20% of critically ill patients. A recent Portuguese study found that more than 14% of ICU patients stayed longer than 14 days. PCI is often associated with ongoing need for life support, such as mechanical ventilation or medications to maintain blood pressure. However, patients may also experience severe muscle weakness, repeated infections, or other complications, which makes this group very diverse. One of the main risk factors for prolonged ICU stay is sepsis, a severe infection that affects the whole body. Other factors-such as prior health conditions, use of corticosteroids, sedation practices, early versus late mobilization, fluid and antibiotic management, and delirium treatment-may also influence the development and course of PCI. This study aims to identify different clinical patterns ("clusters") among critically ill patients who remain in the ICU for more than 10 days. Patients will be followed until hospital discharge, and up to one year if data are available. Understanding these different patterns will help develop more personalized and effective care strategies for each patient profile. The study is a multicenter retrospective cohort including adult patients (≥18 years) admitted to participating ICUs for more than 5 days between 2021 and 2023. Data collected will include demographic, clinical, and laboratory information, details of organ support (such as mechanical ventilation or vasopressors), medications, nutrition, and rehabilitation practices. Statistical and machine learning methods will be used to identify groups of patients with similar clinical trajectories and to assess how these groups are related to outcomes such as survival, recovery of organ function, or long-term disability. Expected results are the identification of distinct clinical clusters of PCI that combine clinical and laboratory data, and the development of tailored management strategies to improve recovery and outcomes for patients with PCI.
Key facts
- Study ID
- NCT07510776
- Run by
- Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
- People needed
- 7000
- Starts
- 2025-01-13
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients aged 18 years or older;
- ICU length of stay equal to or greater than 5 days.
You may not qualify if…
- Patients with an ICU stay < 5 days;
- Patients discharged from the ICU early due to lack of ward availability, rather than clinical recovery;
- Patients who do not survive the early phase of critical illness (i.e., early ICU deaths).
Where it is running
- Centro Hospitalar de São João / ULS São João — Lisbon, Lisbon District, Portugal (enrolling)
- Hospital de Vila Franca de Xira / ULS Estuário do Tejo — Lisbon, Lisbon District, Portugal (enrolling)
- Hospital Garcia de Orta / ULS Almada-Seixal — Lisbon, Lisbon District, Portugal (enrolling)
- Hospital Prof. Doutor Fernando Fonseca / ULS Amadora -Sintra — Lisbon, Lisbon District, Portugal (enrolling)
- Hospital Santa Maria / ULS Santa Maria — Lisbon, Lisbon District, Portugal (enrolling)
- Hospital São Francisco Xavier / Centro Hospitalar de Lisboa Ocidental — Lisbon, Lisbon District, Portugal (enrolling)
- Hospital de VIla Nova de Gaia-Espinho / ULS Gaia e Espinho — Vila Nova de Gaia, Porto District, Portugal
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.